Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling Journal Article


Authors: Dahari, H; Cotler, S. J.; Layden, T. J.; Perelson, A. S.
Article Title: Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling
Journal Title: Journal of hepatology
Volume: 58
Issue: 4
ISSN: 1600-0641; 0168-8278
Publisher: Unknown  
Journal Place: Netherlands
Date Published: 2013
Start Page: 840
End Page: 842
Language: eng
DOI/URL:
Notes: GR: AI028433/AI/NIAID NIH HHS/United States; GR: AI065256/AI/NIAID NIH HHS/United States; GR: OD011095/OD/NIH HHS/United States; GR: P20-RR018754/RR/NCRR NIH HHS/United States; GR: R01 AI028433/AI/NIAID NIH HHS/United States; GR: R01 AI078881/AI/NIAID NIH HHS/United States; GR: R01 OD011095/OD/NIH HHS/United States; GR: R56/R01-AI078881/AI/NIAID NIH HHS/United States; JID: 8503886; CON: J Hepatol. 2012 Mar;56(3):557-63. PMID: 22027585; CIN: J Hepatol. 2013 Apr;58(4):842-3. PMID: 23246702; NIHMS466174; OID: NLM: NIHMS466174 [Available on 04/01/14]; OID: NLM: PMC3667977 [Available on 04/01/14]; PMCR: 2014/04/01 00:00; 2012/05/10 [received]; 2012/07/10 [revised]; 2012/08/28 [accepted]; 2012/12/13 [aheadofprint]; ppublish
LUC Authors
  1. Harel Dahari
    70 Dahari
  2. Thomas Layden
    5 Layden
  3. Scott Cotler
    82 Cotler